Collegium Pharmaceutical: Are On A Consolidated Basis, Which Includes Both Azstarys And Adlarity®, An Fdaapproved Alzheimer’s Product That Was Not Part Of The Acquisition And Is No Longer Actively Commercialized By The Seller Parties. The Company Did Not Acquire Adlarity. Azstarys Constituted Substantially All Of Corium’s Consolidated Operations, And Accordingly Corium’s Consolidated Financial Statements Are Presented Pursuant To Rule305 Of Regulation Sx
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameCollegium Pharmaceutical, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









